Detection of Recurrent Cervical Cancer by Whole-body FDG PET Scans

References

1. ↵
   1. Bodurka-Bevers D,
   2. Morris M,
   3. Eifel P.

   Posttherapy surveillance of women with cervical cancer: an out come analysis. Gynecol Oncol 2000; 78: 187-193.

   OpenUrlCrossRefPubMedWeb of Science
2. 1. Philip J and
   2. William T.

   Clinical Gynecologic Oncology. Health science Asia, Elsevier Science 2002.
3. ↵
   1. Crowe JP Jr.,
   2. Adler LP,
   3. Shenk RR, et al.

   Positron emission tomography and breast masses:comparison with clinical, mammographic, and pathological findings. Ann Surg Oncol 1994; 1: 132-140.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   1. Knight SB,
   2. Delbeke D,
   3. Stewart JR, et al.

   Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy. Chest 1996; 109: 982-988.

   OpenUrlCrossRefPubMedWeb of Science
5. 1. Grigsby PW,
   2. Siegel BA,
   3. Dehdashti F.

   Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 2001; 19: 3745-3749.

   OpenUrlAbstract/FREE Full Text
6. ↵
   1. Chang TC,
   2. Law KS,
   3. Hong JH, et al.

   Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during followup for patients with cervical malignancies: a phase II study. Cancer 2004; 101: 164-171.

   OpenUrlCrossRefPubMed
7. ↵
   1. Unger JB,
   2. Ivy JJ,
   3. Connor P, et al.

   Detection of recurrent cervical cancer by whole body FDG PET scan in asymptomatic and symptomatic women. Gynecol Oncol 2004; 94: 212-216.

   OpenUrlCrossRefPubMed
8. ↵
   1. Havrilesky LK,
   2. Wong TZ,
   3. Secord AA, et al.

   The role of PET scanning in the detection of recurrent cervical cancer. Gynecol Oncol 2003; 90: 186-190.

   OpenUrlCrossRefPubMed
9. ↵
   1. Rose PG,
   2. Adler LP,
   3. Rodriguea M, et al.

   Position emission tomography for evaluation para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clincal Oncol 1999; 17: 41-45.

   OpenUrl
10. ↵
    1. Sakurai H,
    2. Suzuki Y,
    3. Nonaka T, et al.

    FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy-tumor volume and FDG uptake value. Gynecol Oncol 2006; 100: 601-607.

    OpenUrlCrossRefPubMed
11. 1. Chung HH,
    2. Kim SK,
    3. Kim TH, et al.

    Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: From diagnosis to prognosis. Gynecol Oncol 2006;103:165-170.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    1. Li XS and
    2. Zhou CW.

    Summary of the evaluation of CT, MRI and PET in Cervical cancer before the operation and during the follow-up. J Development in Cancer 2006; 2: 119-122 (Chinese).

    OpenUrl
13. ↵
    1. Park DH,
    2. Kim KH,
    3. Park SY, et al.

    Diagnosis of recurrent uterine cervical cancer: computed tomograph versus position emission tomograph. Korean J Radiol 2000; 1: 51-55.

    OpenUrlPubMed